NL8702294A - Farmaceutische preparaten met aanhoudende afgifte. - Google Patents
Farmaceutische preparaten met aanhoudende afgifte. Download PDFInfo
- Publication number
- NL8702294A NL8702294A NL8702294A NL8702294A NL8702294A NL 8702294 A NL8702294 A NL 8702294A NL 8702294 A NL8702294 A NL 8702294A NL 8702294 A NL8702294 A NL 8702294A NL 8702294 A NL8702294 A NL 8702294A
- Authority
- NL
- Netherlands
- Prior art keywords
- composition according
- preparation
- hydroxypropylmethylcellulose
- microcrystalline cellulose
- acetylsalicylic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868624213A GB8624213D0 (en) | 1986-10-09 | 1986-10-09 | Sustained release pharmaceutical compositions |
| GB8624213 | 1986-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8702294A true NL8702294A (nl) | 1988-05-02 |
Family
ID=10605478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8702294A NL8702294A (nl) | 1986-10-09 | 1987-09-25 | Farmaceutische preparaten met aanhoudende afgifte. |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JPS63101334A (hu) |
| KR (1) | KR880004801A (hu) |
| AU (1) | AU7942087A (hu) |
| BE (1) | BE1000732A5 (hu) |
| CA (1) | CA1332809C (hu) |
| CH (1) | CH675831A5 (hu) |
| DE (1) | DE3733540A1 (hu) |
| DK (1) | DK527487A (hu) |
| ES (1) | ES2014518A6 (hu) |
| FI (1) | FI874414A (hu) |
| FR (1) | FR2604902B1 (hu) |
| GB (2) | GB8624213D0 (hu) |
| GR (1) | GR871550B (hu) |
| HU (1) | HU201875B (hu) |
| IL (1) | IL84104A0 (hu) |
| IT (1) | IT1221493B (hu) |
| LU (1) | LU87009A1 (hu) |
| NL (1) | NL8702294A (hu) |
| NO (1) | NO874200L (hu) |
| NZ (1) | NZ222083A (hu) |
| PH (1) | PH24227A (hu) |
| PT (1) | PT85880B (hu) |
| SE (1) | SE8703889L (hu) |
| ZA (1) | ZA877617B (hu) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5948437A (en) * | 1996-05-23 | 1999-09-07 | Zeneca Limited | Pharmaceutical compositions using thiazepine |
| US5895663A (en) * | 1997-07-31 | 1999-04-20 | L. Perrigo Company | Pseudoephedrine hydrochloride extended-release tablets |
| KR100660594B1 (ko) * | 1999-03-31 | 2006-12-22 | 얀센 파마슈티카 엔.브이. | 방출 조절형 제제중의 프리젤라틴화 전분 |
| US6242003B1 (en) | 2000-04-13 | 2001-06-05 | Novartis Ag | Organic compounds |
| US20060127474A1 (en) | 2001-04-11 | 2006-06-15 | Oskar Kalb | Pharmaceutical compositions comprising fluvastatin |
| SE0102888D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| SE0102887D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| SE0102886D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| TWI338583B (en) | 2004-05-20 | 2011-03-11 | Otsuka Pharma Co Ltd | Solid pharmaceutical formulation |
| EP1803447B1 (en) * | 2004-09-09 | 2009-07-22 | Psicofarma, S.A. De C.V. | Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE795766A (fr) * | 1972-02-22 | 1973-08-22 | Lilly Co Eli | Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules |
| US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US4520009A (en) * | 1983-11-28 | 1985-05-28 | Verex Laboratories, Inc. | Sustained released aspirin formulation |
| DE3346571A1 (de) * | 1983-12-23 | 1985-07-04 | Bayer Ag, 5090 Leverkusen | Oral retardierte acetylsalicylsaeureformulierungen |
| KR850700212A (ko) * | 1984-03-21 | 1985-12-26 | 죠지 드모트 | 서방성 약제학적 캼셀제 |
-
1986
- 1986-10-09 GB GB868624213A patent/GB8624213D0/en active Pending
-
1987
- 1987-09-25 NL NL8702294A patent/NL8702294A/nl not_active Application Discontinuation
- 1987-09-25 HU HU874311A patent/HU201875B/hu not_active IP Right Cessation
- 1987-10-02 BE BE8701131A patent/BE1000732A5/fr not_active IP Right Cessation
- 1987-10-02 FR FR878713759A patent/FR2604902B1/fr not_active Expired - Lifetime
- 1987-10-02 CH CH3838/87A patent/CH675831A5/de not_active IP Right Cessation
- 1987-10-03 DE DE19873733540 patent/DE3733540A1/de not_active Withdrawn
- 1987-10-06 IL IL84104A patent/IL84104A0/xx unknown
- 1987-10-06 LU LU87009A patent/LU87009A1/fr unknown
- 1987-10-06 KR KR870011168A patent/KR880004801A/ko not_active Application Discontinuation
- 1987-10-07 FI FI874414A patent/FI874414A/fi not_active IP Right Cessation
- 1987-10-07 AU AU79420/87A patent/AU7942087A/en not_active Abandoned
- 1987-10-07 GB GB8723515A patent/GB2195893B/en not_active Expired - Lifetime
- 1987-10-07 GR GR871550A patent/GR871550B/el unknown
- 1987-10-07 NZ NZ222083A patent/NZ222083A/en unknown
- 1987-10-07 PT PT85880A patent/PT85880B/pt not_active IP Right Cessation
- 1987-10-07 NO NO874200A patent/NO874200L/no unknown
- 1987-10-08 DK DK527487A patent/DK527487A/da not_active Application Discontinuation
- 1987-10-08 ES ES8702873A patent/ES2014518A6/es not_active Expired - Lifetime
- 1987-10-08 CA CA000548872A patent/CA1332809C/en not_active Expired - Lifetime
- 1987-10-08 IT IT48469/87A patent/IT1221493B/it active
- 1987-10-08 JP JP62256149A patent/JPS63101334A/ja active Pending
- 1987-10-08 SE SE8703889A patent/SE8703889L/ not_active Application Discontinuation
- 1987-10-08 PH PH35906A patent/PH24227A/en unknown
- 1987-10-09 ZA ZA877617A patent/ZA877617B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT52958A (en) | 1990-09-28 |
| PT85880B (pt) | 1990-07-31 |
| FR2604902B1 (fr) | 1991-04-26 |
| FI874414A0 (fi) | 1987-10-07 |
| CA1332809C (en) | 1994-11-01 |
| PT85880A (en) | 1987-11-01 |
| SE8703889L (sv) | 1988-04-10 |
| LU87009A1 (fr) | 1988-05-03 |
| ZA877617B (en) | 1989-05-30 |
| HU201875B (en) | 1991-01-28 |
| GB2195893B (en) | 1991-05-08 |
| ES2014518A6 (es) | 1990-07-16 |
| DK527487D0 (da) | 1987-10-08 |
| PH24227A (en) | 1990-05-04 |
| FI874414A (fi) | 1988-04-10 |
| GB8723515D0 (en) | 1987-11-11 |
| DK527487A (da) | 1988-04-10 |
| KR880004801A (ko) | 1988-06-27 |
| AU7942087A (en) | 1988-04-14 |
| FR2604902A1 (fr) | 1988-04-15 |
| GB8624213D0 (en) | 1986-11-12 |
| GB2195893A (en) | 1988-04-20 |
| NZ222083A (en) | 1991-05-28 |
| CH675831A5 (hu) | 1990-11-15 |
| IT8748469A0 (it) | 1987-10-08 |
| IL84104A0 (en) | 1988-03-31 |
| NO874200D0 (no) | 1987-10-07 |
| SE8703889D0 (sv) | 1987-10-08 |
| DE3733540A1 (de) | 1988-04-14 |
| GR871550B (en) | 1988-02-15 |
| JPS63101334A (ja) | 1988-05-06 |
| BE1000732A5 (fr) | 1989-03-21 |
| IT1221493B (it) | 1990-07-06 |
| NO874200L (no) | 1988-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI330080B (en) | Solid pharmaceutical compositions containing pregabalin | |
| Bredenberg et al. | In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance | |
| AU2009326084B2 (en) | Ulipristal acetate tablets | |
| AU776645B2 (en) | Pregelatinized starch in a controlled release formulation | |
| US20170007543A1 (en) | Sustained release of guaifenesin | |
| SE453797B (sv) | Terapeutisk, solid enhetsdoseringsform med forlengt utlosningsmonster vars berarmaterial innehaller hydroxypropylmetylcellulosa med hog molekyler vikt | |
| JP2009501801A (ja) | イブプロフェンとファモチジンとを含有する医薬およびその投与 | |
| BRPI0709847A2 (pt) | composiÇço farmacÊutica, tablete deglutÍvel, uso de uma composiÇço, processo para preparar uma composiÇço farmacÊutica | |
| JP2000511170A (ja) | 医薬組成物 | |
| AU2004275469A1 (en) | HRT formulations | |
| KR20090101048A (ko) | 활성 성분의 방출을 조절할 수 있는 가분성 생약 형태 | |
| KR102158948B1 (ko) | 약물 전달 시스템 | |
| US20070298096A1 (en) | Analgesic/Antipyretic Compositions for Enhanced Absorption | |
| Mohapatra et al. | Formulation, development and evaluation of patient friendly dosage forms of metformin, Part-I: Orally disintegrating tablets | |
| JP2008536922A (ja) | オランザピンの医薬用経口崩壊錠 | |
| NL8702294A (nl) | Farmaceutische preparaten met aanhoudende afgifte. | |
| US20040022851A1 (en) | Sustained release of guaifenesin combination drugs | |
| KR101046789B1 (ko) | 안정성이 개선된 암로디핀 속붕해성 정제 및 그의 제조방법 | |
| JPS6087217A (ja) | 一定放出速度の固体調剤テオフイリン配合物 | |
| Karunanithy | Development and Evaluation of Multi-Layer Controlled Release Tablet of Pentoxifylline | |
| DK166563B1 (da) | Buccal komposition | |
| Prema | Formulation and Evaluation of Immediate Release Tablets of a Model Anti-Migraine Drug | |
| Anusha | Formulation and Evaluation of Sorafenib Tosylate Film Coated Tablets. | |
| Lokhande | Design and Evaluation of Sustained Release Matrix Tablets of Atenolol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BV | The patent application has lapsed |